Envoy Medical Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +18.8% | -37.9% | +15.3% | -17.6% | -25.0% | +9.5% | +69.6% | -46.2% | +78.6% | -48.0% | +30.8% | – | |
| – | +23.8% | -34.6% | +60.1% | -23.7% | -16.0% | +43.9% | +3.5% | -13.2% | +3.9% | +48.3% | -11.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +65.1% | -22.7% | +9.8% | +6.4% | -10.4% | +11.2% | -9.6% | +8.7% | +68.6% | -20.0% | -14.0% | – | |
| – | +193.7% | -29.7% | -24.7% | +6.1% | -16.1% | +28.2% | +13.6% | +18.1% | -34.5% | +17.4% | +8.0% | – | |
| – | +101.0% | -27.0% | -2.5% | +3.4% | -9.0% | +11.7% | -0.3% | +12.9% | +12.7% | -9.0% | -6.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +266.7% | +100.0% | +45.5% | +28.9% | +26.1% | -24.5% | +375.2% | -100.0% | – | – | |
| – | -413.2% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -413.2% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -404.5% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.